We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+11.99%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.96B
AUM Growth
+$565M
Cap. Flow
-$238M
Cap. Flow %
-2.66%
Top 10 Hldgs %
14.1%
Holding
748
New
26
Increased
189
Reduced
394
Closed
36

Top Buys

Rank Stock Value
1
STAG icon
STAG Industrial
STAG
+$26.5M
2
CRI icon
Carter's
CRI
+$23.3M
3
HWC icon
Hancock Whitney
HWC
+$19.5M
4
UL icon
Unilever
UL
+$16.7M
5
MTDR icon
Matador Resources
MTDR
+$15.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.98%
2 Industrials 16.66%
3 Technology 16.47%
4 Financials 13.37%
5 Consumer Discretionary 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMGN
201
DELISTED
Immunogen Inc
IMGN
$11.3M 0.13%
2,274,564
+1,395,603
+159% +$7.57M
SRDX
202
DELISTED
Surmodics
SRDX
$11.2M 0.13%
329,660
+34,516
+12% +$1.16M
CNMD icon
203
CONMED
CNMD
$1.39B
$11.2M 0.13%
126,693
+8,479
+7% +$704K
DIS icon
204
Walt Disney
DIS
$167B
$11.2M 0.12%
128,623
-4,360
-3% -$417K
MEDP icon
205
Medpace
MEDP
$16.1B
$11.1M 0.12%
52,048
-15,657
-23% -$3.13M
WMT icon
206
Walmart Inc
WMT
$885B
$11M 0.12%
231,999
+4,260
+2% +$202K
CXT icon
207
Crane NXT
CXT
$2.99B
$11M 0.12%
314,087
-76,081
-19% -$2.65M
POWI icon
208
Power Integrations
POWI
$3.38B
$10.9M 0.12%
152,434
+10,571
+7% +$754K
SHW icon
209
Sherwin-Williams
SHW
$82.7B
$10.9M 0.12%
45,843
-309
-0.7% -$71.4K
HALO icon
210
Halozyme
HALO
$9.79B
$10.6M 0.12%
186,854
-3,853
-2% -$197K
KO icon
211
Coca-Cola
KO
$377B
$10.6M 0.12%
166,065
-123
-0.1% -$7.43K
HLI icon
212
Houlihan Lokey
HLI
$8.77B
$10.6M 0.12%
121,066
+38,915
+47% +$3.5M
AMED
213
DELISTED
Amedisys
AMED
$10.5M 0.12%
125,348
-39,885
-24% -$3.6M
HXL icon
214
Hexcel
HXL
$7.79B
$10.4M 0.12%
177,091
+12,317
+7% +$705K
LW icon
215
Lamb Weston
LW
$7.22B
$10.2M 0.11%
114,362
-403
-0.4% -$34.3K
SMPL icon
216
Simply Good Foods
SMPL
$901M
$10.2M 0.11%
268,172
+18,602
+7% +$686K
ADUS icon
217
Addus HomeCare
ADUS
$2.16B
$10.2M 0.11%
102,204
+7,072
+7% +$739K
APH icon
218
Amphenol
APH
$198B
$10.1M 0.11%
265,630
-3,054
-1% -$116K
ONTO icon
219
Onto Innovation
ONTO
$12.9B
$10M 0.11%
147,469
+10,206
+7% +$733K
DCI icon
220
Donaldson
DCI
$10.9B
$10M 0.11%
170,191
-10,054
-6% -$576K
NEO icon
221
NeoGenomics
NEO
$1.96B
$9.87M 0.11%
1,068,713
-43,161
-4% -$402K
FANG icon
222
Diamondback Energy
FANG
$57.1B
$9.79M 0.11%
71,572
-1,472
-2% -$215K
EOG icon
223
EOG Resources
EOG
$79.2B
$9.78M 0.11%
75,496
-93
-0.1% -$12.4K
SPY icon
224
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$9.72M 0.11%
25,431
-820
-3% -$315K
MORN icon
225
Morningstar
MORN
$7.22B
$9.67M 0.11%
44,651
-5,516
-11% -$1.26M

Similar funds

Segall Bryant & Hamill's Q4 2022 Portfolio in Review

As of Q4 2022, Segall Bryant & Hamill held 748 positions worth $8.96B, up 6.7% from $8.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Segall Bryant & Hamill's Q4 2022 filing shows 26 new, 189 increased, 394 reduced and 36 closed positions. Its largest new stake was STAG Industrial: 847,354 shares worth $27.4M. The largest sale was CATALENT, INC., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

  • Segall Bryant & Hamill's largest Q4 2022 buy was STAG Industrial: 847,354 shares worth $27.4M.
  • Segall Bryant & Hamill added most to Hancock Whitney in Q4 2022, an estimated $19.5M increase.
  • Segall Bryant & Hamill's biggest Q4 2022 reduction was CATALENT, INC., cutting an estimated $32.8M.
  • Segall Bryant & Hamill fully exited Avalara, Inc. in Q4 2022, selling an estimated $10.9M.
  • Segall Bryant & Hamill's ten largest holdings make up 14% of its $8.96B portfolio in Q4 2022.
  • Segall Bryant & Hamill opened 26 new positions and closed 36 in Q4 2022.
  • Segall Bryant & Hamill's portfolio value rose 6.7% quarter-over-quarter to $8.96B.

Based on Segall Bryant & Hamill's 13F filing for Q4 2022, filed 14 Feb 2023.